Ad
TVTX Short Information Travere Therapeutics Inc Com
home / stock / tvtx / tvtx short
Short Information | Travere Therapeutics Inc Com (NASDAQ:TVTX)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 5,966,731 |
| Total Actual Volume | 36,273,294 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 298,337 |
| Average Short Percentage | 14.75% |
Is there a TVTX Short Squeeze or Breakout about to happen?
See the TVTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
TVTX Twenty Trading Day's Volume to Short Volume Chart
TVTX Twenty Trading Day Price Chart
TVTX Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 09-17-2024 | $14.32 | $14.4 | $14.79 | $14.005 | 2,749,378 | 564,903 | 20.55% |
| 09-16-2024 | $13.41 | $14.27 | $14.72 | $13.22 | 3,738,987 | 971,654 | 25.99% |
| 09-13-2024 | $12.89 | $13.48 | $13.57 | $12.57 | 2,318,159 | 485,940 | 20.96% |
| 09-12-2024 | $12.12 | $12.6 | $12.74 | $11.89 | 1,331,086 | 145,078 | 10.9% |
| 09-11-2024 | $12.68 | $12.24 | $12.72 | $12.13 | 1,316,503 | 301,748 | 22.92% |
| 09-10-2024 | $12.9 | $12.84 | $13.18 | $12.401 | 1,972,346 | 260,206 | 13.19% |
| 09-09-2024 | $11.52 | $12.86 | $13.16 | $11.5 | 4,211,061 | 538,914 | 12.8% |
| 09-06-2024 | $10.8 | $10.98 | $11.91 | $10.64 | 7,893,838 | 1,133,567 | 14.36% |
| 09-05-2024 | $10.15 | $9.93 | $10.355 | $9.435 | 1,236,224 | 109,550 | 8.86% |
| 09-04-2024 | $9.51 | $10.05 | $10.105 | $9.34 | 1,954,582 | 466,171 | 23.85% |
| 09-03-2024 | $9.49 | $9.6 | $10.25 | $9.36 | 1,427,387 | 343,945 | 24.1% |
| 08-30-2024 | $9.39 | $9.47 | $9.65 | $9.35 | 819,143 | 120,378 | 14.7% |
| 08-29-2024 | $9.03 | $9.36 | $9.75 | $8.9781 | 968,180 | 57,304 | 5.92% |
| 08-28-2024 | $9.08 | $9.03 | $9.16 | $8.83 | 443,901 | 57,980 | 13.06% |
| 08-27-2024 | $9.06 | $9.06 | $9.19 | $8.88 | 407,635 | 28,357 | 6.96% |
| 08-26-2024 | $9.04 | $9.05 | $9.12 | $8.9341 | 547,580 | 42,997 | 7.85% |
| 08-23-2024 | $8.64 | $8.98 | $9.22 | $8.5 | 790,520 | 57,813 | 7.31% |
| 08-22-2024 | $8.75 | $8.57 | $8.7975 | $8.46 | 709,912 | 129,926 | 18.3% |
| 08-21-2024 | $9.14 | $8.69 | $9.16 | $8.64 | 914,023 | 77,643 | 8.49% |
| 08-20-2024 | $8.97 | $8.9 | $9.16 | $8.8 | 522,849 | 72,657 | 13.9% |
News, Short Squeeze, Breakout and More Instantly...
Travere Therapeutics Inc Com Company Name:
TVTX Stock Symbol:
NASDAQ Market:
Travere Therapeutics Inc Com Website:
Ad
-
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present at the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 9:45 a.m. ET. A live webcast will be accessible on the Investor pa...
-
2024-09-06 11:15:02 ET Citigroup analyst issues BUY recommendation for TVTX on September 6, 2024 09:51AM ET. The previous analyst recommendation was Buy. TVTX was trading at $11.045 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
-
FDA approves expanded indication making FILSPARI available to patients with IgA nephropathy (IgAN) at risk of progression; updated label includes data showing long-term durable benefit on proteinuria and kidney function preservation that accrued over two years Conversion to full approva...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company is increasing the scope of its expanded certified geological technical report on its 100% owned registered concession at the ...